Alan H. Auerbach
Net Worth
Last updated:
What is Alan H. Auerbach net worth?
The estimated net worth of Mr. Alan H. Auerbach is at least $81,971,285 as of 2 Jul 2024. He owns shares worth $35,356,321 as insider, has earned $1,094,964 from insider trading and has received compensation worth at least $45,520,000 in Puma Biotechnology, Inc..
What is the salary of Alan H. Auerbach?
Mr. Alan H. Auerbach salary is $5,690,000 per year as Founder, Chairman, Pres, Chief Executive Officer & Sec. in Puma Biotechnology, Inc..
How old is Alan H. Auerbach?
Mr. Alan H. Auerbach is 55 years old, born in 1970.
What stocks does Alan H. Auerbach currently own?
As insider, Mr. Alan H. Auerbach owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | Founder, Chairman, Pres, Chief Executive Officer & Sec. | 7,085,435 | $4.99 | $35,356,321 |
What does Puma Biotechnology, Inc. do?
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Alan H. Auerbach insider trading
Puma Biotechnology, Inc.
Mr. Alan H. Auerbach has made 60 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 18,885 units of PBYI stock worth $61,735 on 2 Jul 2024.
The largest trade he's ever made was exercising 60,698 units of PBYI stock on 3 Jul 2023. As of 2 Jul 2024 he still owns at least 7,085,435 units of PBYI stock.
Puma Biotechnology key executives
Puma Biotechnology, Inc. executives and other stock owners filed with the SEC:
- Mr. Alan H. Auerbach (55) Founder, Chairman, Pres, Chief Executive Officer & Sec.
- Mr. Douglas Hunt B.Sc., FRAPS (60) Senior Vice President of Regulatory Affairs, Medical Writing & Project Management
- Mr. Jeffrey Jerome Ludwig (59) Chief Commercial Officer
- Mr. Maximo F. Nougues (56) Chief Financial Officer & Principal Accounting Officer